Novel surgical implants in the treatment of childhood glaucoma

Newer devices such as the PRESERFLO, PGI, and ACP demonstrate encouraging mid-term efficacy and safety in the management of childhood glaucoma, particularly in refractory cases or eyes with prior surgeries. While early outcomes are promising, larger comparative studies with extended follow-up are needed to better establish their long-term role relative to conventional GDDs in childhood glaucoma management.